What drug is Asiminib?

Asciminib (scemblix/asciminib) is an oral kinase inhibitor used to treat patients with chronic myelogenous leukemia (CML also known as chronic myeloid leukemia). Approved for the treatment of:Adults with Philadelphia chromosome-positive (Ph+) chronic phase chronic myelogenous leukemiaCP) who have previously received 2 or more tyrosine kinase inhibitors (TKI) drug treatment and T315Imutant chronic myelogenous leukemiaPh+chronic myelogenous leukemia,This mutation will lead to resistance to certain drugs.

Before taking Asiminil , Before starting treatment, tell your doctor of all medical conditions, including if : have a history of inflammation of the pancreas (pancreatitis) , have a history of heart disease or arteries and veins (blood vessel type) , are pregnant, planning to become pregnant, or are breastfeeding. Aximini may harm an unborn baby. Your doctor will perform a pregnancy test before starting treatment. Women who may become pregnant should use effective contraceptive measures during treatment and for one week after the last dose. Consult your doctor about suitable contraceptive methods. If you become pregnant unexpectedly during treatment or think you may be pregnant, tellyour doctor right away. It is unknown whether asiminib passes into breast milk, do not breastfeed during treatment and for 1 week after the last dose. Aximini may cause fertility problems in women, which may affect the ability to have children. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.